PRELUDE CAPITAL MANAGEMENT, LLC - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 51 filers reported holding IRADIMED CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of IRADIMED CORP
ValueSharesWeighting
Q1 2020$9,000
-35.7%
400
-33.3%
0.00%0.0%
Q4 2019$14,000
+75.0%
600
+99.3%
0.00%
Q1 2019$8,000
+14.3%
3010.0%0.00%
Q4 2018$7,000
+16.7%
301
+0.3%
0.00%
Q2 2018$6,000
-93.9%
300
-95.4%
0.00%
-100.0%
Q4 2017$98,000
+326.1%
6,500
+684.1%
0.01%
+100.0%
Q4 2015$23,000
-17.9%
829
-79.3%
0.00%0.0%
Q3 2014$28,0004,0000.00%
Other shareholders
IRADIMED CORP shareholders Q2 2018
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 771,311$34,223,00010.44%
RK Capital 300,800$13,346,4963.16%
Soleus Capital Management, L.P. 628,206$27,873,5002.57%
Ballast Asset Management, LP 25,088$1,113,1551.03%
Bridge City Capital, LLC 28,172$1,249,9920.63%
Ranger Investment Management 212,147$9,412,9620.62%
Bares Capital Management 277,000$12,290,4900.52%
Riverwater Partners LLC 11,636$516,2890.47%
Hillsdale Investment Management Inc. 90,010$3,993,7440.37%
SHAKER INVESTMENTS LLC/OH 12,919$573,2160.32%
View complete list of IRADIMED CORP shareholders